Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$11,725,628
+$2,747,754 QoQ
Shares Held
9,776
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#1,168
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nicholas Hoffman & Company, LLC. holds $35,503,201 across 12 Drug Manufacturers - General names. LLY ranks #1 (33.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,776 | $11,725,628 | |
| 2 | JNJ |
Johnson & Johnson
|
34,137 | $8,669,773 | |
| 3 | ABBV |
AbbVie Inc.
|
10,274 | $2,585,349 | |
| 4 | AZN |
Astrazeneca PLC
|
11,897 | $2,255,909 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
35,055 | $2,019,869 | |
| 6 | GSK |
GSK plc
|
37,580 | $1,969,943 | |
| 7 | MRK |
Merck & Co., Inc.
|
15,146 | $1,946,261 | |
| 8 | NVS |
Novartis AG
|
9,771 | $1,531,311 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,725,628 | 9,776 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $8,977,874 | 9,761 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $11,045,562 | 10,278 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $7,907,732 | 10,364 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,958,221 | 10,209 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $8,016,282 | 9,706 | Shares | Sole | 2025-06-23 | |
| 2024-12-31 | $7,433,588 | 9,629 | Shares | Sole | 2025-06-23 | |
| 2024-09-30 | $9,053,420 | 10,219 | Shares | Sole | 2025-06-23 | |
| 2024-06-30 | $10,755,914 | 11,880 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $9,356,524 | 12,027 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $7,147,765 | 12,262 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $6,632,481 | 12,348 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $7,365,799 | 15,706 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,184,955 | 15,098 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,498,941 | 15,031 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,849,279 | 14,997 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $4,993,790 | 15,402 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,870,576 | 13,516 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,884,205 | 14,062 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,243,479 | 14,038 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $3,387,485 | 14,759 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,663,119 | 14,255 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,357,344 | 13,962 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,053,185 | 13,871 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,228,086 | 13,571 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,876,604 | 13,528 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||